This document provides information on hard gelatin capsules, including their production process, equipment used, quality control tests, and sizes. It discusses the preparation of gelatin, molding capsule halves, drying, trimming, joining, filling, sealing, and packaging processes. Key equipment for filling capsules are also outlined, including elevators, filling machines for powders, granules and liquids, air displacement units, metal detectors, and sorting machines. Standard operating procedures and environmental conditions for capsule filling are also provided.
Capsules are solid dosage forms that contain a drug or mixture of drugs enclosed within a shell. The shell is typically made of gelatin but can also be other materials. Capsules are intended for oral administration and provide rapid release of contents unless they are modified or enteric release capsules. Capsules can be filled using various methods like auger, dosator, or dosing disc systems. Tests are conducted to ensure uniformity of contents, weight, and dissolution based on pharmacopeial standards.
Visual inspection of parenteral products is conducted to detect defective units and ensure compliance with regulatory requirements that injectable products be free of visible particles. All filled containers undergo 100% visual inspection against black and white backgrounds under controlled lighting. Inspections are usually manual but can also be automated. Post-inspection sampling is required and failures can result in batch rejection. Any particles detected must be characterized to identify the source and ensure appropriate corrective actions. Recalls are sometimes necessary when particles are found, posing a risk to patient safety. Thorough training and documentation are needed to support consistent visual inspection.
Hard gelatin capsules consist of two pieces (cap and body) made of gelatin, water, and other ingredients that enclose powders, granules, or pellets. Soft gelatin capsules have a continuous gelatin shell surrounding a liquid core. Capsules offer advantages over tablets like easier swallowing, taste masking, and improved bioavailability. Capsule filling machines use various principles like dosator tubes and tamping to fill capsules to the desired weight in a multi-step automated process. Common problems in filling include capsules not entering or separating properly, weight and size variation, and dents or telescoping, which can be addressed by checking machine settings and alignment, and the properties of
The document describes a Nutsch filter bag, which is a single leaf filter bag with sleeves extending to the bottom of the cylindrical chamber. This divides the bag into two chambers where vacuum and air pressure are used to operate the filtration process. Filter tubes installed in the chamber are enclosed by the vessel and vacuum is created by a pump to start the filtration process and collect dust particles from the air. Key specifications of the Nutsch filter bag are provided.
The document provides details on the components and working of a tablet compression machine. It describes the key parts like the hopper, feeder system, punches, die system, turret, cam tracks and their functions. The principles of tablet formation through compression of granules between the upper and lower punches in the die is explained. The various stages of the tablet compression process - filling, metering, compression and ejection are outlined. Terminology related to punches, dies and other parts are defined.
IPQC and FPQC tests are important quality control steps for creams from raw materials to finished product. Creams are topical semisolid preparations used to deliver drugs to the skin. They can be oil-in-water or water-in-oil emulsions. Evaluation of creams includes tests for physical properties, pH, viscosity, spreadability, irritancy, microbial growth, and preservative efficacy. Creams are packaged in jars or tubes and stored properly to ensure stability.
This document discusses in-process quality control (IPQC) tests for parenteral products. It describes several key IPQC tests including drug content assays, clarity testing to detect particulate matter using various methods, leakage testing of ampoules using dye bath or spark tests, sterility testing using membrane filtration or direct inoculation methods, and endotoxin/pyrogen testing. Maintaining strict quality controls during manufacturing is important for ensuring parenterals are sterile, pyrogen-free, and free of particulate matter when injected into the body.
This document discusses pharmaceutical capsules and their manufacturing process. It begins with an introduction stating that capsules are widely used, cost efficient, and easy to manufacture. The document then outlines various sections that will discuss properties of powders used in capsules, types of capsules, hard and soft capsule filling processes, advantages and disadvantages of capsules, effects of lubricants, and challenges in manufacturing. Tables and figures are referenced to provide experimental results. The conclusion emphasizes that capsules are an important delivery system and that powder properties must be considered to improve filling machine performance.
Capsules are solid dosage forms that contain a drug or mixture of drugs enclosed within a shell. The shell is typically made of gelatin but can also be other materials. Capsules are intended for oral administration and provide rapid release of contents unless they are modified or enteric release capsules. Capsules can be filled using various methods like auger, dosator, or dosing disc systems. Tests are conducted to ensure uniformity of contents, weight, and dissolution based on pharmacopeial standards.
Visual inspection of parenteral products is conducted to detect defective units and ensure compliance with regulatory requirements that injectable products be free of visible particles. All filled containers undergo 100% visual inspection against black and white backgrounds under controlled lighting. Inspections are usually manual but can also be automated. Post-inspection sampling is required and failures can result in batch rejection. Any particles detected must be characterized to identify the source and ensure appropriate corrective actions. Recalls are sometimes necessary when particles are found, posing a risk to patient safety. Thorough training and documentation are needed to support consistent visual inspection.
Hard gelatin capsules consist of two pieces (cap and body) made of gelatin, water, and other ingredients that enclose powders, granules, or pellets. Soft gelatin capsules have a continuous gelatin shell surrounding a liquid core. Capsules offer advantages over tablets like easier swallowing, taste masking, and improved bioavailability. Capsule filling machines use various principles like dosator tubes and tamping to fill capsules to the desired weight in a multi-step automated process. Common problems in filling include capsules not entering or separating properly, weight and size variation, and dents or telescoping, which can be addressed by checking machine settings and alignment, and the properties of
The document describes a Nutsch filter bag, which is a single leaf filter bag with sleeves extending to the bottom of the cylindrical chamber. This divides the bag into two chambers where vacuum and air pressure are used to operate the filtration process. Filter tubes installed in the chamber are enclosed by the vessel and vacuum is created by a pump to start the filtration process and collect dust particles from the air. Key specifications of the Nutsch filter bag are provided.
The document provides details on the components and working of a tablet compression machine. It describes the key parts like the hopper, feeder system, punches, die system, turret, cam tracks and their functions. The principles of tablet formation through compression of granules between the upper and lower punches in the die is explained. The various stages of the tablet compression process - filling, metering, compression and ejection are outlined. Terminology related to punches, dies and other parts are defined.
IPQC and FPQC tests are important quality control steps for creams from raw materials to finished product. Creams are topical semisolid preparations used to deliver drugs to the skin. They can be oil-in-water or water-in-oil emulsions. Evaluation of creams includes tests for physical properties, pH, viscosity, spreadability, irritancy, microbial growth, and preservative efficacy. Creams are packaged in jars or tubes and stored properly to ensure stability.
This document discusses in-process quality control (IPQC) tests for parenteral products. It describes several key IPQC tests including drug content assays, clarity testing to detect particulate matter using various methods, leakage testing of ampoules using dye bath or spark tests, sterility testing using membrane filtration or direct inoculation methods, and endotoxin/pyrogen testing. Maintaining strict quality controls during manufacturing is important for ensuring parenterals are sterile, pyrogen-free, and free of particulate matter when injected into the body.
This document discusses pharmaceutical capsules and their manufacturing process. It begins with an introduction stating that capsules are widely used, cost efficient, and easy to manufacture. The document then outlines various sections that will discuss properties of powders used in capsules, types of capsules, hard and soft capsule filling processes, advantages and disadvantages of capsules, effects of lubricants, and challenges in manufacturing. Tables and figures are referenced to provide experimental results. The conclusion emphasizes that capsules are an important delivery system and that powder properties must be considered to improve filling machine performance.
The document discusses packaging of parenterals. It defines packaging and describes the importance of packaging in protecting pharmaceutical products and maintaining quality. The ideal package should protect the contents from environmental, mechanical and other hazards, and not interact with or alter the contents. Primary packaging directly contains the product while secondary and tertiary packaging provide additional layers of protection. Common packaging materials include glass, plastic, metal and rubber. The document outlines the types and qualities of primary and secondary packaging as well as various closures used.
The document discusses the manufacturing process of parenteral preparations. It describes parenterals as sterile liquids or solids for injection or implantation. The manufacturing process involves planning, material management, production, quality control testing, filling, and packaging. Production areas are divided into strict zones based on cleanliness. Environmental controls and facility design aim to prevent contamination, with areas for filling, weighing, storage, and administration. Personnel flow and utility locations are also considered for efficiency.
The document discusses form fill and seal (FFS) or blow fill seal (BFS) technology used in pharmaceutical packaging. BFS is a process where plastic containers are formed, filled with sterile product, and sealed in a single integrated machine within a sterile environment. It has become a prevalent aseptic processing technique over the last 20 years. The basic BFS process involves extruding a plastic tube, molding it into a container within the mold, filling the container, sealing it, and discharging the finished package. It reduces personnel and validation requirements compared to traditional packaging. While it has advantages like reduced costs, it also has challenges like particulate and temperature control that require mitigation strategies.
Blow-fill-seal technology is a manufacturing technique used to produce small and large liquid filled containers. It involves extruding a plastic tube, molding it into a container within a sterile environment, filling the container, and sealing it. Our company Rommelag has been a leader in developing blow-fill-seal technology since the 1960s. The process provides sterile, automated filling with reduced human intervention and is widely used today to package pharmaceutical products like oral solutions and parenterals.
This document discusses pharmaceutical packaging technology. It defines pharmaceutical packaging and outlines ideal packaging requirements. The key functions of packaging are then described, including product identification, protection, facilitating use, promotion, marketing, convenience, barrier protection and security. Various packaging materials are also discussed, including glass, metals, rubbers, plastics, fibrous materials and films. Specific plastic materials like polyethylene, polypropylene, polyvinyl chloride and polyvinylidene chloride are explained in terms of their properties and uses in pharmaceutical packaging.
Tài liệu GMP được chia sẻ bởi GMPc Việt Nam - Nhà tư vấn Sáng tạo, Chuyên nghiệp, Toàn diện Dự án Nhà máy GMP (EU, PIC/S, WHO, ASEAN), ISO 13485:2012, ISO/IEC 17025:2005, ISO 15189:2012, ISO 15378:2011, ISO 9001:2008
This document discusses critical material attributes (CMA), critical process parameters (CPP), and critical quality attributes (CQA) for various pharmaceutical unit operations used in manufacturing oral solid dosage forms. It provides examples of CMAs, CPPS, and CQAs for common processes like blending, granulation, drying, compaction, and tableting. The goal is to identify material traits and processing conditions that most impact the critical quality standards of the finished drugs.
This document discusses methods for testing the integrity of membrane filters, specifically sterilizing-grade filters with a 0.22 μm pore size. It describes both destructive and non-destructive tests. Destructive tests involve challenging filters with bacteria to check retention ability, while non-destructive tests like the bubble point, diffusion, and pressure hold tests allow filters to be checked before and after use without compromising sterility. The bubble point test measures the minimum pressure required to force liquid out of pores and correlate to pore size. The diffusion test measures low gas flow through a wetted membrane under pressure. The pressure hold test monitors upstream pressure changes over time to detect gas diffusion.
The document discusses the blow-fill-seal (BFS) technology used to aseptically produce sterile pharmaceutical products. It describes the BFS process which combines plastic container formation via blow/vacuum molding with aseptic filling. Strict controls and validations are required to minimize contamination risks, including clean room classification and environmental monitoring, cleaning and sterilization processes, personnel training and maintenance procedures. Broth fill tests are conducted to qualify the aseptic filling capability and demonstrate sterility assurance levels better than 10^-3 can be achieved.
Capsules are solid dosage forms that enclose one or more active ingredients within a soluble shell, typically made of gelatin. There are two main types: hard-shelled capsules containing dry powders, and soft-shelled capsules used for oils. Capsules are manufactured through a process involving dipping pins in gelatin solutions to form the shells, drying, stripping from the pins, trimming, joining the cap and body portions, and polishing. Various sizes of empty capsules are commercially available. Capsules offer benefits like ease of swallowing and unit dosing but require specialized filling equipment for industrial production.
This document provides information about tablets, including their definition, categories, in-process tests, and testing methods. Tablets are solid oral dosage forms containing medicaments. There are several categories including uncoated, film coated, sugar coated, and modified release tablets. In-process tests include uniformity of contents, weight, dissolution, and disintegration. Dissolution and disintegration tests are described for different tablet types using specified apparatus, media, and time/acceptance criteria. Modified and prolonged release tablets have additional dissolution testing methods and criteria for acid and buffer stages.
This document discusses various visual defects that can occur during tablet processing, including capping, lamination, chipping, cracking, sticking, picking, binding, and double impression. For each defect, the document describes the causes related to formulation, processing, and machine settings, and provides potential remedies. Some common causes mentioned are insufficient or improper binders/lubricants, too dry or moist granules, deep die concavities, worn dies, and improper machine settings. Suggested remedies include modifying the formulation, drying the granules, increasing binder/lubricant amounts, adjusting machine settings, and replacing worn parts.
This document provides a summary of capsules, including their history, types, manufacturing process, evaluation, and key details. It discusses how gelatin capsules were first developed in the 18th century and how the process has evolved. The main types - hard gelatin capsules, soft gelatin capsules, and their composition, sizes, and manufacturing processes - are outlined. Methods for evaluating capsules like uniformity of weight, drug content testing, disintegration testing, and dissolution testing are also summarized.
The JLab Instruments Leak Test Apparatus is used to test the quality of packaging seals for food, drugs, and other products contained in strips, blisters, and sachets. It generates a vacuum inside a desiccator housing to test if the packaging retains its shape or if dye penetrates through any holes in the seals when immersed in a solution after the vacuum is released. The instrument features a microcontroller, LED display, soft-touch keys, and integrated vacuum pump for creating vacuum within 30 seconds to hold for a preset time up to 9999 seconds.
Pharmaceutical development report (pdr)Atul Bhombe
The document discusses the key sections and guidelines for an effective Pharmaceutical Development Report (PDR) as outlined in ICH Q8 and Q8(R1). The six critical sections of a PDR are: 1) active and inactive ingredients, 2) formulation development and properties, 3) manufacturing process development, 4) container closure system, 5) microbiological attributes, and 6) compatibility with diluents. The PDR provides a comprehensive understanding of the product and manufacturing process for regulatory review and should be updated throughout the product lifecycle.
Blow Fill Seal technology is a specialized packaging technique that forms, fills, and seals containers in a continuous sterile process without human intervention. The process involves extruding plastic into a tube, molding containers, filling them with liquid, sealing the containers, and discharging the finished product. Key advantages are reduced human contact and economies of scale in packaging pharmaceutical liquids aseptically in small and large volumes for uses like injectables, respiratory products, and ophthalmic solutions.
This document discusses various types of machinery used for packing, labeling, and printing pharmaceutical products. It describes machinery for blister packing, capsule filling, ampoule filling, liquid filling, tube filling, and shrink wrapping. It also discusses semi-automatic and fully automatic labeling machines. The key functions of this machinery are to accurately package pharmaceuticals, apply labels with important product information, and protect products during transport and storage.
This document discusses tablet coating. It begins by providing a brief history of tablet coating and then discusses the reasons for coating tablets, including changing appearance, taste masking, and protecting ingredients from environmental conditions. It describes the three basic components of tablet coating: tablet properties, the coating process, and coating compositions. Under coating process, it discusses coating equipment types like conventional coating pans and fluidized bed coaters. It also covers coating parameters and types of coatings like sugar coating and film coating.
This document provides an introduction to fluidized bed processing, which involves coating, granulation, and drying of particulate materials. It describes the different types of spray processes in fluidized beds, including top spray, bottom spray, and tangential spray. Bottom spray processing, developed by Dr. Dale Wurster, is commonly used in pharmaceutical applications for coating uniformity. The document outlines the key components of a fluidized bed coater and discusses important process parameters like inlet temperature, spray rate, and batch size that can impact performance. Formulation factors like coating solution strength and batch size are also reviewed. Fluidized bed processing is used to improve drug properties like taste, appearance, and release characteristics.
This document provides an overview of fluidized bed processing (FBP). It discusses the principle of fluidization, how FBP works, its components, and applications. FBP uses air to fluidize solid particles, allowing for high rates of heat and mass transfer. This makes it useful for granulation, drying, and coating processes. It has advantages like high drying rates and easy handling but also disadvantages like potential for product loss and requirement of skilled operators. FBP is widely used in pharmaceutical manufacturing for applications like granule drying, tablet coating, and functional powder coating.
1. This document discusses the scale up considerations for producing capsules in a pilot plant setting. It covers the various unit operations involved in capsule production like mixing, granulation, drying, lubrication, filling and finishing.
2. Key factors that must be considered during scale up for each unit operation are discussed, such as blender load, mixing time, drying temperature and airflow, amount of lubricant added, filling machine parameters, and polishing methods. Process controls and quality checks are also important to ensure quality and reproducibility.
3. Proper facility layout and environmental controls are required to maintain cGMP standards as the capsule production process is scaled up.
The document discusses packaging of parenterals. It defines packaging and describes the importance of packaging in protecting pharmaceutical products and maintaining quality. The ideal package should protect the contents from environmental, mechanical and other hazards, and not interact with or alter the contents. Primary packaging directly contains the product while secondary and tertiary packaging provide additional layers of protection. Common packaging materials include glass, plastic, metal and rubber. The document outlines the types and qualities of primary and secondary packaging as well as various closures used.
The document discusses the manufacturing process of parenteral preparations. It describes parenterals as sterile liquids or solids for injection or implantation. The manufacturing process involves planning, material management, production, quality control testing, filling, and packaging. Production areas are divided into strict zones based on cleanliness. Environmental controls and facility design aim to prevent contamination, with areas for filling, weighing, storage, and administration. Personnel flow and utility locations are also considered for efficiency.
The document discusses form fill and seal (FFS) or blow fill seal (BFS) technology used in pharmaceutical packaging. BFS is a process where plastic containers are formed, filled with sterile product, and sealed in a single integrated machine within a sterile environment. It has become a prevalent aseptic processing technique over the last 20 years. The basic BFS process involves extruding a plastic tube, molding it into a container within the mold, filling the container, sealing it, and discharging the finished package. It reduces personnel and validation requirements compared to traditional packaging. While it has advantages like reduced costs, it also has challenges like particulate and temperature control that require mitigation strategies.
Blow-fill-seal technology is a manufacturing technique used to produce small and large liquid filled containers. It involves extruding a plastic tube, molding it into a container within a sterile environment, filling the container, and sealing it. Our company Rommelag has been a leader in developing blow-fill-seal technology since the 1960s. The process provides sterile, automated filling with reduced human intervention and is widely used today to package pharmaceutical products like oral solutions and parenterals.
This document discusses pharmaceutical packaging technology. It defines pharmaceutical packaging and outlines ideal packaging requirements. The key functions of packaging are then described, including product identification, protection, facilitating use, promotion, marketing, convenience, barrier protection and security. Various packaging materials are also discussed, including glass, metals, rubbers, plastics, fibrous materials and films. Specific plastic materials like polyethylene, polypropylene, polyvinyl chloride and polyvinylidene chloride are explained in terms of their properties and uses in pharmaceutical packaging.
Tài liệu GMP được chia sẻ bởi GMPc Việt Nam - Nhà tư vấn Sáng tạo, Chuyên nghiệp, Toàn diện Dự án Nhà máy GMP (EU, PIC/S, WHO, ASEAN), ISO 13485:2012, ISO/IEC 17025:2005, ISO 15189:2012, ISO 15378:2011, ISO 9001:2008
This document discusses critical material attributes (CMA), critical process parameters (CPP), and critical quality attributes (CQA) for various pharmaceutical unit operations used in manufacturing oral solid dosage forms. It provides examples of CMAs, CPPS, and CQAs for common processes like blending, granulation, drying, compaction, and tableting. The goal is to identify material traits and processing conditions that most impact the critical quality standards of the finished drugs.
This document discusses methods for testing the integrity of membrane filters, specifically sterilizing-grade filters with a 0.22 μm pore size. It describes both destructive and non-destructive tests. Destructive tests involve challenging filters with bacteria to check retention ability, while non-destructive tests like the bubble point, diffusion, and pressure hold tests allow filters to be checked before and after use without compromising sterility. The bubble point test measures the minimum pressure required to force liquid out of pores and correlate to pore size. The diffusion test measures low gas flow through a wetted membrane under pressure. The pressure hold test monitors upstream pressure changes over time to detect gas diffusion.
The document discusses the blow-fill-seal (BFS) technology used to aseptically produce sterile pharmaceutical products. It describes the BFS process which combines plastic container formation via blow/vacuum molding with aseptic filling. Strict controls and validations are required to minimize contamination risks, including clean room classification and environmental monitoring, cleaning and sterilization processes, personnel training and maintenance procedures. Broth fill tests are conducted to qualify the aseptic filling capability and demonstrate sterility assurance levels better than 10^-3 can be achieved.
Capsules are solid dosage forms that enclose one or more active ingredients within a soluble shell, typically made of gelatin. There are two main types: hard-shelled capsules containing dry powders, and soft-shelled capsules used for oils. Capsules are manufactured through a process involving dipping pins in gelatin solutions to form the shells, drying, stripping from the pins, trimming, joining the cap and body portions, and polishing. Various sizes of empty capsules are commercially available. Capsules offer benefits like ease of swallowing and unit dosing but require specialized filling equipment for industrial production.
This document provides information about tablets, including their definition, categories, in-process tests, and testing methods. Tablets are solid oral dosage forms containing medicaments. There are several categories including uncoated, film coated, sugar coated, and modified release tablets. In-process tests include uniformity of contents, weight, dissolution, and disintegration. Dissolution and disintegration tests are described for different tablet types using specified apparatus, media, and time/acceptance criteria. Modified and prolonged release tablets have additional dissolution testing methods and criteria for acid and buffer stages.
This document discusses various visual defects that can occur during tablet processing, including capping, lamination, chipping, cracking, sticking, picking, binding, and double impression. For each defect, the document describes the causes related to formulation, processing, and machine settings, and provides potential remedies. Some common causes mentioned are insufficient or improper binders/lubricants, too dry or moist granules, deep die concavities, worn dies, and improper machine settings. Suggested remedies include modifying the formulation, drying the granules, increasing binder/lubricant amounts, adjusting machine settings, and replacing worn parts.
This document provides a summary of capsules, including their history, types, manufacturing process, evaluation, and key details. It discusses how gelatin capsules were first developed in the 18th century and how the process has evolved. The main types - hard gelatin capsules, soft gelatin capsules, and their composition, sizes, and manufacturing processes - are outlined. Methods for evaluating capsules like uniformity of weight, drug content testing, disintegration testing, and dissolution testing are also summarized.
The JLab Instruments Leak Test Apparatus is used to test the quality of packaging seals for food, drugs, and other products contained in strips, blisters, and sachets. It generates a vacuum inside a desiccator housing to test if the packaging retains its shape or if dye penetrates through any holes in the seals when immersed in a solution after the vacuum is released. The instrument features a microcontroller, LED display, soft-touch keys, and integrated vacuum pump for creating vacuum within 30 seconds to hold for a preset time up to 9999 seconds.
Pharmaceutical development report (pdr)Atul Bhombe
The document discusses the key sections and guidelines for an effective Pharmaceutical Development Report (PDR) as outlined in ICH Q8 and Q8(R1). The six critical sections of a PDR are: 1) active and inactive ingredients, 2) formulation development and properties, 3) manufacturing process development, 4) container closure system, 5) microbiological attributes, and 6) compatibility with diluents. The PDR provides a comprehensive understanding of the product and manufacturing process for regulatory review and should be updated throughout the product lifecycle.
Blow Fill Seal technology is a specialized packaging technique that forms, fills, and seals containers in a continuous sterile process without human intervention. The process involves extruding plastic into a tube, molding containers, filling them with liquid, sealing the containers, and discharging the finished product. Key advantages are reduced human contact and economies of scale in packaging pharmaceutical liquids aseptically in small and large volumes for uses like injectables, respiratory products, and ophthalmic solutions.
This document discusses various types of machinery used for packing, labeling, and printing pharmaceutical products. It describes machinery for blister packing, capsule filling, ampoule filling, liquid filling, tube filling, and shrink wrapping. It also discusses semi-automatic and fully automatic labeling machines. The key functions of this machinery are to accurately package pharmaceuticals, apply labels with important product information, and protect products during transport and storage.
This document discusses tablet coating. It begins by providing a brief history of tablet coating and then discusses the reasons for coating tablets, including changing appearance, taste masking, and protecting ingredients from environmental conditions. It describes the three basic components of tablet coating: tablet properties, the coating process, and coating compositions. Under coating process, it discusses coating equipment types like conventional coating pans and fluidized bed coaters. It also covers coating parameters and types of coatings like sugar coating and film coating.
This document provides an introduction to fluidized bed processing, which involves coating, granulation, and drying of particulate materials. It describes the different types of spray processes in fluidized beds, including top spray, bottom spray, and tangential spray. Bottom spray processing, developed by Dr. Dale Wurster, is commonly used in pharmaceutical applications for coating uniformity. The document outlines the key components of a fluidized bed coater and discusses important process parameters like inlet temperature, spray rate, and batch size that can impact performance. Formulation factors like coating solution strength and batch size are also reviewed. Fluidized bed processing is used to improve drug properties like taste, appearance, and release characteristics.
This document provides an overview of fluidized bed processing (FBP). It discusses the principle of fluidization, how FBP works, its components, and applications. FBP uses air to fluidize solid particles, allowing for high rates of heat and mass transfer. This makes it useful for granulation, drying, and coating processes. It has advantages like high drying rates and easy handling but also disadvantages like potential for product loss and requirement of skilled operators. FBP is widely used in pharmaceutical manufacturing for applications like granule drying, tablet coating, and functional powder coating.
1. This document discusses the scale up considerations for producing capsules in a pilot plant setting. It covers the various unit operations involved in capsule production like mixing, granulation, drying, lubrication, filling and finishing.
2. Key factors that must be considered during scale up for each unit operation are discussed, such as blender load, mixing time, drying temperature and airflow, amount of lubricant added, filling machine parameters, and polishing methods. Process controls and quality checks are also important to ensure quality and reproducibility.
3. Proper facility layout and environmental controls are required to maintain cGMP standards as the capsule production process is scaled up.
The document discusses the layout, equipment, and processes required for the production of solid oral dosage forms like tablets in a pharmaceutical manufacturing facility. It provides details on the building facilities, various production areas and equipment for activities such as granulation, drying, milling, blending, compression, coating, packaging and quality control tests. The layout is designed for proper material and air flow following cGMP guidelines. Commonly used equipment for different processes are also outlined.
The document provides information about the Talboys high throughput homogenizer. It is designed to homogenize samples in a microplate or vial format to allow for high throughput processing. Samples are placed in wells or vials with grinding balls and buffer, then processed rapidly in the homogenizer. The homogenizer can effectively process various sample types such as tissues, seeds, and cultures. Installation and operating instructions are provided, along with safety guidelines and tips for use. Maintenance is not required beyond cleaning, and the homogenizer is built for long-term dependable use.
This document provides information on small scale and large scale capsule filling machines. It discusses the components and types of capsules, as well as various filling methods like the punch method, Feton capsule filling, auger filling, vibration-assisted filling, and piston tamp filling. Specific capsule filling machine models are described from companies like Lilly/Parke-Davis, Farmatic, Hofliger & Karg, Macofar, mG2, Osaka, Perry, and Zanasi. Capsule sealing and recent filling equipment are also summarized briefly in less than 3 sentences.
Small scale and large scale capsule filling machineceutics1315
This document summarizes small and large scale capsule filling machines. It describes the components and manufacturing of hard and soft gelatin capsules. Various filling methods are discussed including direct, indirect, and vacuum-assisted techniques. Specific machines from companies like Lilly, Farmatic, Hofliger & Karg, Macofar, mG2, Osaka, and Zanasi are outlined with their models and capacities. Capsule sealing and recent filling equipment are also briefly covered. In summary, the document provides an overview of capsule manufacturing processes and machinery used at different production scales.
The report provides an overview of Krishna Kumar's one month industrial training at Navkar Lifesciences Pvt. Ltd., including descriptions of the company's facilities, products, production processes like tablet granulation and coating, and equipment used. Key steps in tablet manufacturing involved mixing, granulation, drying, milling, lubrication, compression, and coating. Problems that can occur during processing and ways to address them are also summarized.
The document provides information on the design and operation of a pharmaceutical pilot plant. It discusses why pilot plants are used, including to evaluate processes at a larger scale and identify critical issues. The summary describes the key objectives of a pilot plant as producing stable dosage forms on a small scale, reviewing equipment, and providing manufacturing guidelines. It also touches on using the pilot plant to design for tablet and capsule production specifically.
Sree Prakash Pandey- VARIOUS DISSOLUTION TESTING METHOD.pptxSreePrakashPandey
This document provides an overview of various dissolution testing methods. It begins with definitions of dissolution and an explanation of the need for dissolution testing. It then describes the major classification of methods as official and unofficial. The official methods discussed in detail are the basket, paddle, reciprocating cylinder, flow through cell, paddle over disk, and rotating cylinder apparatuses. The unofficial methods briefly outlined include beaker, rotating/static disk, flask stirrer, peristalsis, rotating bottle, and dialysis methods. The document concludes with applications and references.
The document discusses various dissolution testing methods and apparatuses. It describes the need for dissolution testing to estimate the rate of drug release from solid oral dosage forms. Common dissolution testing conditions involve simulating gastric and intestinal fluids at 37°C. Four common apparatuses are described for immediate-release and controlled-release drug products: the basket, paddle, reciprocating cylinder, and flow-through cell apparatuses. Limitations of the basket and paddle apparatuses are noted. Additional apparatuses for transdermal and topical dosage forms as well as the Franz diffusion cell are also summarized.
Hard gelatin capsules - a detailed studyTeny Thomas
The presentation involves a descriptive study on hard gelatin capsules which includes the production of the hard gelatin capsule shell, size of the capsules, capsule filling machines and the finishing techniques. The presentation also involves the special techniques of capsule formulation and the quality control tests of hard gelatin capsules
ASAD REZA INDUSTRIAL TRAINING PRESENTATION (2).pptxMewar University
This presentation summarizes the process of manufacturing tablets. It discusses the key steps which include sieving and mixing the active ingredients and excipients, drying the granules in a fluidized bed dryer, milling to the desired size, blending, compression using tablet presses to form the tablets, coating for properties like taste-masking or controlled release, packaging in blisters or strips with secondary packaging like boxes, and quality control testing of the tablets. The presentation provides an overview of the various unit operations and equipment involved at each stage of tablet manufacturing.
The document discusses the importance and objectives of pilot plants in the pharmaceutical industry. It explains that pilot plants are used to transform lab-scale formulas into viable products by developing reliable manufacturing procedures. The key objectives of pilot plants are to produce stable dosage forms, identify critical process features, provide manufacturing formulas, and find issues before large-scale production. The document also describes various unit operations involved in pilot plant scale-up like granulation, drying, blending, and compression. It emphasizes that the pilot plant helps evaluate these operations at a small scale to guide large-scale production.
The document describes the design of a pilot plant for producing tablets and capsules. It includes organizational structures for managing production, with the pilot plant controlled by pharmaceutical research. It also details various unit operations involved in tablet and capsule production like blending, granulation, drying, milling, compression, coating, and filling capsules. Scale-up considerations are discussed for each unit operation when transferring processes from laboratory to production scale. Process validation and quality systems for the pilot plant are also summarized.
The document summarizes the process of media fill validation for aseptic processing. It discusses key aspects of a media fill including the number and frequency of runs, choice of growth medium, number of units filled, interventions monitored, and acceptance criteria. A media fill aims to validate that the aseptic process is capable of preventing contamination under worst-case conditions. It must duplicate the manufacturing process and capture potential issues from personnel, equipment, or the environment. Successful media fills provide evidence the process is robust and can consistently produce sterile products.
The document discusses scale up considerations for producing tablets at a pilot plant scale. The primary responsibilities of the pilot plant staff are to ensure efficient, economic, and consistent reproducibility of newly formulated tablets on a production scale. Key stages of tablet production include material handling, dry blending, granulation, drying, size reduction, blending, compression, and slugging. Process parameters like granulation feed rate and compression properties must be optimized during pilot plant trials to facilitate large scale production of solid dosage forms.
This document discusses various dissolution apparatus used to test the dissolution of pharmaceutical dosage forms. It describes the 7 main types of apparatus specified in pharmacopeias like USP including basket, paddle, flow-through cell and reciprocating cylinder apparatuses. Each type of apparatus has a specific design and is used to test different dosage forms like tablets, capsules, transdermal patches based on simulating their dissolution environment in the body. Dissolution testing provides critical information for quality control and drug development.
PILOT PLANT AND SCALE UP TECHNIQUES -.=.pptxShubham ghodke
The document discusses pilot plant and scale up techniques for pharmaceutical manufacturing. It defines a pilot plant as where a lab scale formula is transformed into a viable product through developing a practical manufacturing procedure. Scale up is the process of designing a prototype using data from the pilot plant. The document outlines general considerations for pilot plants including personnel requirements, equipment, production rates and GMP compliance. It also discusses advantages such as facilitating technology transfer and disadvantages like reduced direct interaction between formulators and production staff. Product considerations for solid dosage forms such as granulation, drying, tablet coating and capsule filling are also covered.
This document discusses pilot plant and scale up techniques for pharmaceutical manufacturing. It defines a pilot plant as transforming a lab-scale formula into a viable product through developing a reliable manufacturing procedure. The significance is that it allows for examination of formulas, equipment review, and determining if raw materials meet specifications. General considerations include reporting structure, personnel requirements, space needs, raw materials, equipment, production rates, and process evaluation. GMP considerations and product-specific techniques are also outlined for various dosage forms.
Transdermal drug delivery systems are formulations that deliver active drugs through the skin for systemic circulation. They provide advantages like avoiding first-pass hepatic metabolism and allowing extended therapy. The document discusses the definition, advantages, limitations and components of transdermal drug delivery systems. It describes the different routes of drug penetration through the skin, ideal drug properties, types of systems and factors affecting their design like skin permeation. Evaluation methods for transdermal patches including adhesion, release and permeation tests are also summarized.
This document provides an overview of sonophoretic drug delivery. It defines sonophoresis as the enhancement of drug migration through the skin using ultrasonic energy. The document discusses the history, mechanisms, safety considerations, applications and advantages of sonophoresis. It notes that sonophoresis increases kinetic energy and disrupts lipid bilayers in the skin to enhance permeation of various drugs including corticosteroids, local anesthetics and salicylates. Proper selection of ultrasound parameters and synergistic use with other enhancers can optimize transdermal drug delivery using this technique.
This document discusses self-microemulsifying drug delivery systems (SMEDDS). It begins with an introduction to SMEDDS and explains they are isotropic mixtures that can form microemulsions upon mild agitation and dilution in the GI tract. It then covers the definition of SMEDDS, the difference between SMEDDS and self-emulsifying drug delivery systems (SEDDS), the composition of SMEDDS including oils, surfactants, co-solvents and polymers. The document discusses the mechanism of emulsification for SMEDDS and factors affecting SMEDDS. It provides details on characterizing and solidifying SMEDDS before concluding with advantages and recent advances.
This document discusses supercritical and subcritical fluid technology for drug delivery applications. It begins with definitions of critical temperature and pressure as well as supercritical fluids. It then describes various processes that use supercritical fluids like CO2 as solvents or antisolvents to precipitate drug particles, including RESS, PGSS, SAS, ASES, GAS, and SEDS. It provides details on the equipment and operating parameters for each process. The document discusses how these techniques can be used for particle engineering applications like size reduction and modifying solid state properties. Finally, it outlines other applications of supercritical fluids like extraction, sterilization and chromatography.
The document discusses pellets as a drug delivery system. It defines pellets as small, spherical particulates produced by agglomerating fine powders or granules using suitable equipment. Pellets have uniform shape and size, good flow properties, and can be coated for controlled drug release. The document describes various pelletization techniques like direct pelletization, layering, extrusion-spheronization, and sugar spheres. It also discusses advantages and disadvantages of pellets and recent innovations like melt pelletization, spray drying, and freeze pelletization that allow high drug loading and different release profiles.
This document provides an overview of osmotic drug delivery systems. It defines key terms related to osmosis and osmotic pressure. It describes the need for controlled release drug delivery and lists advantages of osmotic systems like zero-order delivery and predictable release rates. The document discusses various types of osmotic pumps including elementary, multi-chamber, controlled porosity and monolithic systems. It also covers formulation, evaluation and marketed products using osmotic technology.
This document discusses niosomes, which are non-ionic surfactant-based vesicles used for drug delivery. Niosomes are formed through the self-assembly of non-ionic surfactants and can encapsulate drugs in their aqueous core. They have advantages over liposomes like lower cost, greater stability, and not requiring special storage conditions. The document describes the structure of niosomes and factors that affect their size, entrapment efficiency, and drug release. Various preparation methods are outlined, along with characterization techniques and potential therapeutic applications of niosomes.
This document provides an overview of nanotechnology and nanoparticles. It defines nanotechnology as the design, characterization, production and application of structures, devices and systems by controlling shape and size at the nanometer scale. It then discusses various types of nanoparticles like polymeric nanoparticles, solid lipid nanoparticles, liposomes, dendrimers, and their applications. The document also covers methods for preparing nanoparticles, materials used, characterization techniques, drug release, and some commercial nano-pharma products.
This document provides an overview of microencapsulation and microencapsulation drug delivery systems (MDDS). It discusses various microencapsulation processes including coacervation, solvent evaporation, polymer-polymer incompatibility, interfacial polymerization, and in situ polymerization. It also covers characterization techniques, drug release measurement methods, applications of microencapsulation in drug delivery and recent research advances in the field.
Liposomes are spherical vesicles made of phospholipid bilayers that can encapsulate hydrophilic or hydrophobic drugs. They offer several advantages for drug delivery such as protection of encapsulated drugs, controlled release, targeted delivery, and improved pharmacokinetics. There are various methods for preparing liposomes of different sizes and compositions, with the most common being lipid hydration, sonication, and extrusion. Liposomes must be characterized based on their size, lamellarity, drug encapsulation efficiency, and stability to ensure quality for pharmaceutical applications such as drug delivery.
This document provides an overview of iontophoresis drug delivery systems. It begins with definitions and the historical development of iontophoresis. Some key advantages include enhanced drug penetration, control of transdermal rates, and avoiding infection. Disadvantages include the need for drugs to be in aqueous solution and ionized. The document discusses the electrical properties of skin, pathways of ion transport, and mechanisms of iontophoresis. Factors affecting the process and common equipment are also outlined. The document concludes with applications and examples of drugs studied for iontophoretic delivery.
Hydrogels are water-swollen polymer networks that can absorb large amounts of water. They have numerous pharmaceutical and biomedical applications due to their unique bulk and surface properties. Hydrogels can be designed to respond to environmental stimuli like pH, temperature, and ionic strength. This allows for controlled drug release in response to changes in the surrounding conditions. Hydrogels find use in various drug delivery applications like oral, ocular, and subcutaneous delivery due to their biocompatibility and ability to encapsulate and release bioactive compounds.
Chapter on Search Results Web results Gastro retentive drug delivery system ...Dr. RAJESH L. DUMPALA
The document summarizes a seminar on gastroretentive drug delivery systems (GRDDS). It discusses the merits of GRDDS, including delivering drugs to the small intestine and improving bioavailability. Various gastroretentive technologies are described, including floating, expanding, bioadhesive, and high density systems. Factors affecting GRDDS performance and methods for evaluating different GRDDS are also outlined.
This document discusses films and strips for pharmaceutical formulations. It begins by introducing oral dissolving and transdermal films, then discusses the advantages of oral soluble thin films which include larger surface area, precision dosing, and improved patient compliance. Manufacturing methods for films are also covered, such as solvent casting and hot melt extrusion. The document provides examples of drugs that can be formulated into films and lists technologies used to produce oral delivery films. It concludes by discussing formulation aspects of orodispersible films including active ingredients, sweetening agents, and flavors.
This document provides an overview of colon targeted drug delivery systems. It discusses the anatomy of the colon, challenges in delivering drugs to the colon, and various pharmaceutical approaches for colon targeted delivery including pH dependent systems, time dependent systems, microflora activated systems, and multiparticulate systems. Several market formulations that use these approaches are also summarized, including Pentasa, Dipentum, Colazal, and Egalet.
This document discusses quality control testing for hard and soft gelatin capsules. It outlines the raw material testing, finished product testing, and industrial standards for capsules. Raw material testing includes parameters like bloom strength, viscosity, pH, moisture, and microbial limits for gelatin. Finished product tests cover weight variation, content uniformity, disintegration, and dissolution. Additional industrial standards address dimensions, shape, solubility, and odor. Pellicle formation testing examines for microbial film growth on liquid media.
This document provides an overview of tablets, including their definition, advantages, disadvantages, types, additives, granulation processes, equipment used, tableting procedure, and evaluation. Tablets are defined as a compressed solid dosage form containing medicaments with or without excipients. Their advantages include dose precision, low cost, stability, and masking of taste, while disadvantages can include difficulty swallowing and formulation challenges for some drugs. The document discusses various tablet types, additives used, granulation technologies and equipment, the tableting process, and methods for evaluating tablets.
This document outlines the stages involved in product development from identification to commercialization at an industrial research center. It discusses 26 stages from initial literature review and active sourcing to process validation and technology transfer. The objective is to understand the product flow and roles of different departments like R&D, quality assurance, clinical trials, and production in bringing a product from concept to market.
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptxHolistified Wellness
We’re talking about Vedic Meditation, a form of meditation that has been around for at least 5,000 years. Back then, the people who lived in the Indus Valley, now known as India and Pakistan, practised meditation as a fundamental part of daily life. This knowledge that has given us yoga and Ayurveda, was known as Veda, hence the name Vedic. And though there are some written records, the practice has been passed down verbally from generation to generation.
Basavarajeeyam is an important text for ayurvedic physician belonging to andhra pradehs. It is a popular compendium in various parts of our country as well as in andhra pradesh. The content of the text was presented in sanskrit and telugu language (Bilingual). One of the most famous book in ayurvedic pharmaceutics and therapeutics. This book contains 25 chapters called as prakaranas. Many rasaoushadis were explained, pioneer of dhatu druti, nadi pareeksha, mutra pareeksha etc. Belongs to the period of 15-16 century. New diseases like upadamsha, phiranga rogas are explained.
Rasamanikya is a excellent preparation in the field of Rasashastra, it is used in various Kushtha Roga, Shwasa, Vicharchika, Bhagandara, Vatarakta, and Phiranga Roga. In this article Preparation& Comparative analytical profile for both Formulationon i.e Rasamanikya prepared by Kushmanda swarasa & Churnodhaka Shodita Haratala. The study aims to provide insights into the comparative efficacy and analytical aspects of these formulations for enhanced therapeutic outcomes.
Does Over-Masturbation Contribute to Chronic Prostatitis.pptxwalterHu5
In some case, your chronic prostatitis may be related to over-masturbation. Generally, natural medicine Diuretic and Anti-inflammatory Pill can help mee get a cure.
Cell Therapy Expansion and Challenges in Autoimmune DiseaseHealth Advances
There is increasing confidence that cell therapies will soon play a role in the treatment of autoimmune disorders, but the extent of this impact remains to be seen. Early readouts on autologous CAR-Ts in lupus are encouraging, but manufacturing and cost limitations are likely to restrict access to highly refractory patients. Allogeneic CAR-Ts have the potential to broaden access to earlier lines of treatment due to their inherent cost benefits, however they will need to demonstrate comparable or improved efficacy to established modalities.
In addition to infrastructure and capacity constraints, CAR-Ts face a very different risk-benefit dynamic in autoimmune compared to oncology, highlighting the need for tolerable therapies with low adverse event risk. CAR-NK and Treg-based therapies are also being developed in certain autoimmune disorders and may demonstrate favorable safety profiles. Several novel non-cell therapies such as bispecific antibodies, nanobodies, and RNAi drugs, may also offer future alternative competitive solutions with variable value propositions.
Widespread adoption of cell therapies will not only require strong efficacy and safety data, but also adapted pricing and access strategies. At oncology-based price points, CAR-Ts are unlikely to achieve broad market access in autoimmune disorders, with eligible patient populations that are potentially orders of magnitude greater than the number of currently addressable cancer patients. Developers have made strides towards reducing cell therapy COGS while improving manufacturing efficiency, but payors will inevitably restrict access until more sustainable pricing is achieved.
Despite these headwinds, industry leaders and investors remain confident that cell therapies are poised to address significant unmet need in patients suffering from autoimmune disorders. However, the extent of this impact on the treatment landscape remains to be seen, as the industry rapidly approaches an inflection point.
- Video recording of this lecture in English language: https://youtu.be/kqbnxVAZs-0
- Video recording of this lecture in Arabic language: https://youtu.be/SINlygW1Mpc
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Here is the updated list of Top Best Ayurvedic medicine for Gas and Indigestion and those are Gas-O-Go Syp for Dyspepsia | Lavizyme Syrup for Acidity | Yumzyme Hepatoprotective Capsules etc
1. SEMINAR ON
1
By:Rajesh L. Dumpala
(B.Pharm, M. Pharm.) PhD. ( Pursuing)
Research Scientist,
Alembic Research Centre. Vadodara
E.Mail:-rdumpala64@gmail.com
2. CONTENT1. INTRODUCTION TO CAPSULE
1.1 HARD GELATIN CAPSULE
1.1.1 PREPARATION OF HGC WITH PLANT LAYOUT
1.1.2 INDUSTRIAL SCALE EQUIPMENTS
1.1.3 STANDARD OPERATING PROCEDURE
1.1.4 QUALITY CONTROL TESTS
1.2 SOFT GELATIN CAPSULE
2. STUDY QUESTIONS
3. REFERENCES
2
9. Here, the capsules are moulded onto stainless steel Pin Bars which
are dipped into the gelatin solution.
9
10. Once dipped, pin bars rise to upper deck allowing the cap and body
to set on the pins.
10
11. Temperature and humidity controlled air is blown over the mould
pins to remove excess water content from the capsule halves.
Humidity, temperature and gelatin viscosity is precisely monitored
throughout the process.
11
12. Once drying is complete, the Pin Bars enter the Table section which
positions the capsule halves for stripping from the Pins in the
automatic section.
12
13. In the Automatic section, capsule halves are individually stripped
from the Pins.
13
14. The cap and body lengths are precisely trimmed to a ±0.15 mm
tolerance.
14
15. The capsule bodies and caps are joined automatically in the joiner
blocks.
15
16. Finished capsules are pushed onto a
conveyer belt which carries them out to a
container.
Capsule quality is monitored throughout the
production process including size, moisture
content, single wall thickness, and color.
16
17. Capsules are sorted and visually
inspected on Inspection Stations.
Perfect capsules are imprinted
with the client logo on high-speed
capsule printing machines.
Capsules are now ready to be
sterilized and packaged.
17
18. Special computer controlled process system monitors and controls
total capsule manufacturing to ensure optimum out-put of highest
quality capsules.
18
22. Product conveying system
3.Air displacement unit
Empty capsule
sorter elevator
Automatic capsule
filling machine
Check
weigher
Capsule sorter
Dedusting & polishing machine
Metal detection system
22
23. 1. CAPSULE ELEVATOR EQUIPMENT
2. CAPSULE FILLING EQUIPMENT
2.1 POWDER FILLING
2.2 GRANULE FILLING
2.3 PELLETE FILLING
2.4 TABLET FILLING
2.5 LIQUID FILLING
3. AIR DISPLACEMENT UNITS (ADU)
4. METAL DETECTION SYSTEM
5. DEDUSTING & POLISHING MACHINE
6. SORTER FOR DEFECTIVE CAPSULES
23
24. The FCE-100 is a high output elevator
suitable for elevating from a lower level to
higher level.
This unit is extremely useful in fully
automatic lines where the output from
the exit chute of a filling/sorting machine,
which is at a lower level, is connected to
the inlet chute of a polishing machine
which is at a higher level.
Can convey all capsule sizes from 00 to5
Inbuilt blower unit
GMP conforming design
Out put:
1,00,000 capsules/hour
24
25. For more no. of filling machines see www.made-in-china.com
www.fuchang.com
More than hundereds of filling machines are there. 25
26. The AF-90T is a fully automatic capsule filling machine
that can fill a large variety of powder formulations into
hard gelatin capsules.
A pellet filling / tablet filling / capsule in capsule device
is available as an optional attachment.
Output : Up to 90,000 capsules / hour for powder filling
Up to 80,000 capsules /hour for pellet filling
Up to 75,000 capsules /hour for tablet filling
Conforming to cGMP
Savings in manpower costs
26
28. Output: 33,000 capsules per hou
Self-contained horizontal
hydraulic closing system
which eliminates the need
for compressed air .
Internal vacuum pump
TFR 8 Tablet Filling Ring for
inserting tablets into
capsules
28
30. This machine can pack
granular such as salt, sugar,
medicine etc.
30
31. The ADU-100 is a dust extraction
unit.
It is used for collecting loose
powder from the polishing
chamber of the DP-100.
It is also used for cleaning
operations on automatic capsule
filling machines.
The unit removes loose powder,
caps, bodies, and capsules lying
around the machine.
It can also be coupled with
tableting machines for dust
collection.
31
32. 100% online metal detection with
automatic capsule filling machine
The Metal Detection system works on
the Eddy Current Principle using a
focused electromagnetic field.
Dual Channel Phase Sensitive systems
are used. It detects all metals (Ferrous,
non-ferrous / non-magnetic stainless
steel).
It detects very minute particles of
stainless steel and metal flakes
Inadvertently present in formulations
All contact parts are manufactured
with SS:318 as per GMP standards32
33. The DP-100 is an advanced de-dusting
and polishing machine.
More flexibility & higher degree of
operating efficiency and cleanliness
1,20,000 capsules/hr 33
34. The Mini Capsule Sorter is specially
designed for automatic sorting of loose
caps, loose powder and diametrically
defective filled capsules.
It can directly be coupled with any
automatic capsule filling machine.
All contact parts are made of SS-316
and all aluminium parts are specially
plated.
Can sort capsules of sizes 000 to 5
34
35. (1) GENERAL REQUIREMENT:
1.1 The environment condition in which filling of hard gelatin capsule
should be normally carried out is :
Humidity :--------- Not more than 35% RH
Temperature :--- Not more than 25 0C
These conditions should be maintain even work has stopped at
the end of working day and during the week- ends.
1.2 The area around machine should be kept clean at all times.
The machine must be thoroughly cleaned during the
week ends and when there is a product change –over.
35
36. 1.3 The speed gear should not be adjusted when the machine is
running on power.
1.4 Operator should wear rubber gloves, nose mask and head covers
when the machine is operated for filling.
(2) PRELIMINARY OPERATIONS
2.1 The RH in the room or area should be checked and recorded on
manufacturing sheet. Filling should not be started if humidity is
more than 35%.
2.2 The compressed air supply should be turned on and regulator set
at about 5 psi.
2.3 The vacuum pump should be turned on with vacuum hole
blocked and the vacuum adjusted to not less than 600 mm Hg.
36
37. (3) LOADING AND RECTIFICATION
3.1 The setting of the loader and rectifier is checked by rotating the
machine manually with the clutch in the “ON position” and the
adjustments should be made.
3.2 The bag of empty capsule shells should be opened and with a clean
scoop capsules should be loaded into the hopper of the
rectification assembly.
3.3 The capsule holding ring should be placed on the turn –table and
turned clock wise until it stops firmly against the drive pin.
37
38. 3.4 The machine should be run manually to check if the capsules enter
the ring correctly. If not, the necessary adjustments should be
made.
3.5 The main switch of the machine should be switched on and the
vacuum pump started. The vacuum should not be less than 600
mmHg.
3.6 The machine should be started and the clutch lever moved to
the right to bring the capsule loader into action. It should be
checked whether the capsules are loaded properly. If the loading is
satisfactory, the loading of the disc should be completed.
38
39. 3.7 The ring assembly should be subjected to two or three revolutions
on the turn- table in an anti clockwise direction to provide the
capsules additional exposure to vacuum for effective separation of
the bodies from the caps.
3.8 The ring assembly should be removed from the table slowly taking
care to avoid spilling the capsule; if then be placed on the ring of
the machine.
3.9 If the loading and rectification of the capsules are satisfactory the
process should be repeated with another ring assembly.
39
40. (4) FILLING OF POWDER
4.1 The operator should run his hand lightly over the ring to ensure that all
the capsules are below the ring surface,
4.2 The speed of the turntable should be adjusted to the pre-determined
rate. This should not be adjusted while the machine is running on power.
4.3 The drug hopper should be filled with the powder up to the stirring arm.
4.4 The machine should be switched on and the drug hopper pulled over the
face of the moving ring until the stirrer start moving and the powder fills
the capsule bodies.
40
41. 4.5 At the end of one revolution of the ring should be pushed back
smartly in order to avoid double feeding of powder.
4.6 Excess powder from the surface of the ring should be scraped off with
a teflon scraper and the powder should be collected in the dust tray.
4.7 The body ring with the capsules filled with powder should be
removed and the cap ring placed on it and positioned so that the two
rings are joined.
(5) SEALING OF CAPSULES
5.1 The pressure of the compressed air supply should be checked and
adjusted if necessary to between 5.5 kg/sq.cm to 6.5 kg/sq.cm. The
air supply valve should be open.
41
42. DIMENSIONS (in millimeter)
TABLE 1
OUTSIDE DIAMETER
Size CAP (mm) BODY(mm)
#0 7.57 - 7.69 7.26 - 7.38
#1 6.85 - 6.97 6.56 - 6.68
#2 6.28 - 6.40 6.01 - 6.13
TECHNICAL SPECIFICATIONS
The various quality variants are controlled as per
specification prescribed in I.P. 1996 for empty HGC
shell.
42
44. TABLE 5
WEIGHT OF CAPSULES (in milligram) & VOLUME (in CC)
AVERAGE WEIGHT (Deviation ± 5%) & VOLUME (in CC)
Size
Average Weight (mg)
(Avg. of 20 Capsules Taken
Together)
Volume (CC)
#0 96 0.68
#1 76 0.50
#2 63 0.38
TABLE 4
WALL THICKNESS
Size CAP (mm) BODY(mm)
#0 0.190 - 0.210 0.183 - 0.203
#1 0.185 - 0.205 0.181 - 0.201
#2 0.180 - 0.200 0.180 - 0.200
44
45. TABLE 7
MOISTURE CONTENT AND DISINTEGRATION TIME
MOISTURE CONTENT 13.0 % - 16.0 %
DISSOLUTION TIME Less than 15 minutes.
TABLE 6
MICROBIOLOGICAL LIMITS
TOTAL COUNTS OF ORGANISM Less than 1000 / gm
E COLI NIL (Absent)
SALMONELLA NIL (Absent)
TESTS AS PRESCRIBED BY I.P. 1996
45
46. A.PROCEDURE FOR PRODUCT TO PRODUCT CHANGE
OVER
Dedusting external surface – Use a clean nylon brush and vacuum
cleaner.
Dismantling- Remove
A. Filling and Loading turn- tables
B. pusher slide
C. Rectifier, raceway with guide block
D. Magazine
E. Drug hopper, auger and stirrer
F. Peg ring plate
G. Partial fill attachment
46
47. Collect all these parts in a suitable SS container.
CLEANING OF PARTS – clean the above parts by washing with
0.1%Teepol solution and scrubbing with soft clean nylon brush. Rinse
with jet of potable water followed by rinsing with 5 micron filtered water.
CLEANING OF CAPSULE PLATES- capsule plates are soaked in
hot 5 micron filtered water for 5-10min. The holes are cleaned using 0.1%
Teepol solution. Rinse with jet of potable water by dipping in 5 micron
filtered water.
CLEANING OF MACHINE BODY- clean with 0.1% Teepol solution
and scrubbing with soft nylon brush. Clean with potable water.
CONFORMING EFFECTIVENESS OF CLEANING- the water
rinse of product hopper and capsule plates is sent to QC department to
confirm absence of previous product. 47
48. Drying – the cleaned dried parts as mentioned in step 2 are wiped
and dried using a clean lint free duster. The capsule plate has air-dried
and stored in a SS trolley.
Assembling – Resemble all the parts of machine carefully checking
for correctness of assembling and free motion of moving parts.
Replace the filter bag in the vacuum can below the machine with a
clean filter bag.
48
50. I.p.Q.C.
DURING FILLING
WEIGHT VARIATION TEST
MOISTURE CONTENT
LOCK LENGTH
FINAL PRODUcT Q.C.
PHARMACOPOIEAL STANDRAD
UNIFORMITY OF MASS
UNIFORMITY OF CONTENT
DISINTEGRATION TEST
DISSOLUTION TEST
MICROBIAL TEST
INDUSTRIAL STANDRAD
DIMENSION
CAPSULE SHAPE
SOLUBILITY
ODOUR
50
51. INTRODUCTION
PLANT LAY OUT
MANUFACTURING PROCESS
EQUIPMENTS
STANDARD OPERATING PROCEDURE
I.P.Q.C.
FINAL PRODUCT Q.C
51
52. One piece, hermetically sealed soft gelatin shell
containing a liquid, a suspension or semisolid.
Filling volume from 0.1 ml to 20 ml.
Available in different shapes like round oval, oblong,
tube shaped and many more.
52
57. The Shell of the Soft Gelatin Capsules comprises of pure Pharmaceutical grade
Gelatin, a plasticizer ( usually Glycerin ),and other ingredients.
Gelatin Shell raw Materials are accurately weighed and then blended with
demineralized water and melted under vacuum in large stainless steel pressure
tanks.
Completed batches are then transferred to the production lines in heat controlled
receiving tanks in which the gelatin mass is maintained at the required
temperature and viscosity. 57
63. Immediately after manufacture capsules are subjected to
“naptha” wash to remove mineral oil form the outer
surface of the capsule.
Centrifuge is used for capsule washing
Products are pre-shaped, semi dried in tumbler
washer drier units.
Tumbler drier unit having temp. <350C which removes all
the solvent used in washing and 50 – 60% of water
63
64. CAPSULE DRYING TUNNEL SYSTEM is constructed from modular
panels in stainless steel AISI 304.
The tunnels have a laminar flow air filtration unit, which allows a
better and more efficient drying of the capsule products.
64
65. 100% inspection is performed on the external appearance (Improper
Sealing, Color, Soft spot & Seam continuity)
Capsules are manually inspected for physical defects
65
66. Online Automatic Capsule Inspection Machine.
Affordable
3 camera system
120,000 Capsules/hours
INSPECAPS 150
66
67. Capsules are over-printed for logos or trade marks, if required.
Products are strip packed, blister packed, bottle pack and bulk
packed as required.
67
68. During encapsulation
Seal thickness and ribbon thickness
Uniformity of mass
Disintegration time
Fill matrix weight
Temp. of gelatin tank
Capsule shell weight
Moisture content &soft gel hardness at the end of
the drying stage
68
69. PHARMACOPIEAL STANDRAD
ACTIVE INGREDIENT ASSAY
RELATED INGREDIENT ASSAY
UNIFORMITY OF MASS
UNIFORMITY OF CONTENT
DISSOLUTION TEST
MICROBIAL TEST
MOISTURE CONTENT DETERMINATION
RUPTURE TEST
INDUSTRIAL STANDRAD
DIMENSION
CAPSULE SHAPE
SOLUBILITY
ODOUR
69
70. The combination example consists of a high potency insoluble
active in a lipid emulsion, sustained release tablet and a cocktail of
two crystalline active materials.
A combination of release profiles can be incorporated in the system.70
76. Schedule M, Indian Government, 2003,1-43
Pharmaceutical capsules . Second edition
Quality Assurance Guide vol. I& II first edition
Dispensing For Pharmaceutical Students by Cooper and Gunn
How to Practice GMPs by P.P.Sharma
Pharmaceutical Process Validation by LOFTUS and NASH
www.indianindustry.com
www.fujicapsule.com/english/system/seam.htm
http://pharmlabs.unc.edu/capsules/text.htm
www.pharmagel.it/production2.htm
www.drugdeliverytech.com
www.capsugel.com
www.innercaps.com
www.intota.com/viewbio. 76